CV Advisors
BMY icon

CV Advisors’s Bristol-Myers Squibb BMY Stock Holding History

CV Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$749K Hold
12,000
– – 0.13% 67
2026
Q2 		$691K Buy
+12,000
New +$689K 0.13% 70

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

CV Advisors's BMY Position: Q3 2026 in Review

CV Advisors held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 12,000 shares worth $749K. The position accounts for 0.13% of the portfolio, ranked #67.

CV Advisors first reported a position in BMY in Q2 2026 and has held it in 2 quarters since. 762 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • CV Advisors held 12,000 shares of Bristol-Myers Squibb worth $749K as of Q3 2026.
  • CV Advisors left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.13% of CV Advisors's portfolio in Q3 2026, its #67 holding.
  • CV Advisors first reported a position in Bristol-Myers Squibb in Q2 2026 and has held it in 2 quarters since.
  • 762 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on CV Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.